$4.02
-0.34-7.8%
Last update: Nov 5, 3:41 PM
Taysha Gene Therapies Inc
TSHANASDAQ
The average analyst price target for Taysha Gene Therapies is $11.13, 176.9% above the current price. Of 15 analysts, 15 rate it Buy. Targets range from $6 to $17. The latest change came on Sep 17, 2026, when Wolfe Research initiated coverage of Taysha Gene Therapies with an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
